Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)

v3.19.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2017   183,105,910      
Beginning balance at Dec. 31, 2017 $ 3,101,614 $ 1,831 $ 4,416,250 $ (40,539) $ (1,275,928)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 90,090       90,090
Other Comprehensive Income (5,503)     (5,503)  
Stock-based Compensation 2,685   2,685    
Shares Repurchased (in shares)   (9,692,356)      
Shares Repurchased (99,997) $ (97) (99,900)    
Issuance of Restricted Stock (in shares)   109,933      
Issuance of Restricted Stock 0 $ 1 (1)    
Ending balance (in shares) at Mar. 31, 2018   173,523,487      
Ending balance at Mar. 31, 2018 $ 3,088,889 $ 1,735 4,319,034 (46,042) (1,185,838)
Beginning balance (in shares) at Dec. 31, 2018 162,986,045 162,986,045      
Beginning balance at Dec. 31, 2018 $ 3,327,768 $ 1,630 4,227,532 (56,026) (845,368)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 62,242       62,242
Other Comprehensive Income 3,801     3,801  
Stock-based Compensation 2,785   2,785    
Shares Repurchased (in shares)   (3,618,634)      
Shares Repurchased (28,330) $ (37) (28,293)    
Issuance of Restricted Stock (in shares)   54,554      
Issuance of Restricted Stock $ 0 $ 1 (1)    
Ending balance (in shares) at Mar. 31, 2019 159,421,965 159,421,965      
Ending balance at Mar. 31, 2019 $ 3,368,266 $ 1,594 $ 4,202,023 $ (52,225) $ (783,126)